Skip to content

Released May 11, 2026, after the close

10-Q filed May 11, 2026, 41 days after period end · 0001636422-26-000066

Q1 2026 · 10-Q
Revenue$70.76M−10.9% vs Q1 2025−5.3% vs Q4 2025
Net Income-$111.03MN/M vs Q1 2025N/M vs Q4 2025
EPS Diluted-$1.53N/M vs Q1 2025no prior Q4 2025 on file
Operating Income-$106,477,000N/M
Operating Cash Flow$18,511,000+6,511.1%
Free Cash Flowderived$18,173,000N/M
Margins · derived
Operating margin-150.5%−125.1 pt vs Q1 2025
Net margin-156.9%−127.0 pt vs Q1 2025

What the release said

The release

Same quarter

MetricQ1 2026Q1 2025Q1 2024Q1 2023
Revenue$70.76M$79.41M$74.72M$73.87M
Net Income-$111.03M-$23.74M-$20.59M-$33.19M
EPS Diluted-$1.53-$0.35-$0.35-$0.60

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR